401 related articles for article (PubMed ID: 27992223)
1. Revealing the Mechanistic Pathway of Acid Activation of Proton Pump Inhibitors To Inhibit the Gastric Proton Pump: A DFT Study.
Jana K; Bandyopadhyay T; Ganguly B
J Phys Chem B; 2016 Dec; 120(51):13031-13038. PubMed ID: 27992223
[TBL] [Abstract][Full Text] [Related]
2. Reactions of sulfenic acid with 2-mercaptoethanol: a mechanism for the inhibition of gastric (H+-K+)-adenosine triphosphate by omeprazole.
Tutunji MF; Qaisi AM; El-Eswed BI; Tutunji LF
J Pharm Sci; 2007 Jan; 96(1):196-208. PubMed ID: 16998872
[TBL] [Abstract][Full Text] [Related]
3. Reaction of proton pump inhibitors with model peptides results in novel products.
Watson C; Zhu L; Guan S; Machen TE; Forte JG
J Pharmacol Sci; 2013; 122(3):213-22. PubMed ID: 23877017
[TBL] [Abstract][Full Text] [Related]
4. Designed inhibitors with hetero linkers for gastric proton pump H
Jana K; Bandyopadhyay T; Ganguly B
J Mol Graph Model; 2017 Nov; 78():129-138. PubMed ID: 29055186
[TBL] [Abstract][Full Text] [Related]
5. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.
Besancon M; Simon A; Sachs G; Shin JM
J Biol Chem; 1997 Sep; 272(36):22438-46. PubMed ID: 9278394
[TBL] [Abstract][Full Text] [Related]
6. Restoration of acid secretion following treatment with proton pump inhibitors.
Shin JM; Sachs G
Gastroenterology; 2002 Nov; 123(5):1588-97. PubMed ID: 12404233
[TBL] [Abstract][Full Text] [Related]
7. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors.
Shin JM; Cho YM; Sachs G
J Am Chem Soc; 2004 Jun; 126(25):7800-11. PubMed ID: 15212527
[TBL] [Abstract][Full Text] [Related]
8. The stereoselectivity of CYP2C19 on R- and S-isomers of proton pump inhibitors.
Tian C; Zhu L; Yu D; Cao Z; Kang T; Zhu R
Chem Biol Drug Des; 2014 May; 83(5):610-21. PubMed ID: 24350826
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo.
Shin JM; Homerin M; Domagala F; Ficheux H; Sachs G
Biochem Pharmacol; 2006 Mar; 71(6):837-49. PubMed ID: 16405921
[TBL] [Abstract][Full Text] [Related]
10. Studies on (H(+)-K+)-ATPase inhibitors of gastric acid secretion. Prodrugs of 2-[(2-pyridinylmethyl)sulfinyl]benzimidazole proton-pump inhibitors.
Sih JC; Im WB; Robert A; Graber DR; Blakeman DP
J Med Chem; 1991 Mar; 34(3):1049-62. PubMed ID: 1848293
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of gastric K+/H+-ATPase by acid-activated 2-((2-pyridylmethyl)sulphinyl)benzimidazole products.
Beil W; Hannemann H; Mädge S; Sewing KF
Eur J Pharmacol; 1987 Jan; 133(1):37-45. PubMed ID: 3030771
[TBL] [Abstract][Full Text] [Related]
12. Binding of omeprazole to protein targets identified by monoclonal antibodies.
Cartee NMP; Wang MM
PLoS One; 2020; 15(9):e0239464. PubMed ID: 32946534
[TBL] [Abstract][Full Text] [Related]
13. Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole.
Nishioka K; Nagao T; Urushidani T
Biochem Pharmacol; 1999 Oct; 58(8):1349-59. PubMed ID: 10487539
[TBL] [Abstract][Full Text] [Related]
14. [Possible mechanisms for (H+ + K+)-ATPase inhibition by proton pump inhibitors, omeprazole, lansoprazole and SCH 28080].
Nagaya H; Satoh H
Nihon Rinsho; 1992 Jan; 50(1):26-32. PubMed ID: 1311786
[TBL] [Abstract][Full Text] [Related]
15. Different biochemical modes of action of two irreversible H+,K(+)-ATPase inhibitors, omeprazole and E3810.
Morii M; Takeguchi N
J Biol Chem; 1993 Oct; 268(29):21553-9. PubMed ID: 8408006
[TBL] [Abstract][Full Text] [Related]
16. Relative efficacies of gastric proton-pump inhibitors on a milligram basis: desired and undesired SH reactions. Impact of chirality.
Kromer W
Scand J Gastroenterol Suppl; 2001; (234):3-9. PubMed ID: 11768559
[TBL] [Abstract][Full Text] [Related]
17. Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo.
Shin JM; Sachs G
Biochem Pharmacol; 2004 Dec; 68(11):2117-27. PubMed ID: 15498502
[TBL] [Abstract][Full Text] [Related]
18. The pharmacology of the gastric acid pump: the H+,K+ ATPase.
Sachs G; Shin JM; Briving C; Wallmark B; Hersey S
Annu Rev Pharmacol Toxicol; 1995; 35():277-305. PubMed ID: 7598495
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective Metabolism of Omeprazole by Cytochrome P450 2C19 and 3A4: Mechanistic Insights from DFT Study.
Jana K; Bandyopadhyay T; Ganguly B
J Phys Chem B; 2018 Jun; 122(22):5765-5775. PubMed ID: 29741901
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of the gastric H+,K(+)-ATPase by omeprazole and related compounds.
Lorentzon P; Bayati A; Lee H; Andersson K
Ann N Y Acad Sci; 1997 Nov; 834():592-9. PubMed ID: 9405870
[No Abstract] [Full Text] [Related]
[Next] [New Search]
